Ivan A. Valdez, PhD
Founder & Principal, Valdez BioStrategy — a Harvard-trained biomedical scientist and former healthcare strategy consultant.
Founder-led scientific strategy
Founder & Principal, Valdez BioStrategyValdez BioStrategy is led by Ivan A. Valdez, PhD, a Harvard-trained biomedical scientist with deep experience in diabetes and metabolic disease research, translational science, and healthcare strategy consulting. His work bridges mechanistic biology, clinical relevance, competitive landscape analysis, and scientific communication.
- PhD, Biological and Biomedical Sciences, Harvard University / Joslin Diabetes Center
- Postdoctoral training in diabetes and metabolism at UT Health San Antonio
- Research experience at UT Southwestern
- Former healthcare strategy consultant at Fletcher Spaght
- Scientific focus: islet biology, beta-cell function, incretin biology, type 2 diabetes, obesity, translational metabolism
Depth where it matters
The practice is grounded in diabetes, obesity, and metabolic disease — incretin biology, islet biology and beta-cell function, glucagon biology, and translational metabolism — and brings mechanistic depth together with the strategic judgment to turn it into clear direction.
Engagements are founder-led: Ivan leads each engagement directly, drawing on the advisory bench only when a scoped question calls for complementary expertise.
Have a scientific strategy question?
For confidential biotech, spinout, investor, or strategic diligence inquiries, start with a brief scoping conversation.
Request a confidential scoping call